欢迎访问missav
欢迎访问missav
, （共同第一）, , , , , , , , , , . A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma. Clinical and Translational Medicine, 2021, 11(5):e419.
2、 , , , , , , , , , （通讯作者）.Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma. Journal of Cancer, 2021, 12(11):3190-3197.
3、, , , ,, , ,（通讯作者）.Cancer death and potential years of life lost in Feicheng City, China: Trends from 2013 to 2018.Medicine.2021 ,100(39):e27370.
4、, , , , , , , , , , , , , （通讯作者）. Long-Term Effectiveness of One-Time Endoscopic Screening for Esophageal Cancer: A Community-BasedStudy in Rural China. Cancer, 2020,126(20):4511-4520.
5、 ,, , , （通讯作者）. Risk factors for precancerous lesions of esophageal squamous cell carcinoma in high-risk areas of rural China: A population-based screening study. Medicine, 2020, 99(31):e21426.
6、, , , , , , , , , , , （通讯作者）. Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population. Journal of Cancer, 2019, 10(14):3284-3290.
7、 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , （通讯作者） , . Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study. BMC Cancer. 2018 ,18(1):435.
8、 , , ,, , （通讯作者）, （通讯作者）. The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China. PLoS One. 2017 ,12(3):e0173211.
9、,（通讯作者）, , , , , , . Patterns of cancer screening, incidence and treatment disparities in China: protocol for a population-based study. BMJ open, 2016, 6(8):e012028.
10、Jinlin Wang, Tao Zhang, Xiaotao Shen, Jia Liu, Deli Zhao, Yawen Sun, Lu Wang, Yingjun Liu, Xiaoyun Gong, Yanxun Liu, Zhengjiang Zhu, Fuzhong Xue. Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS. Metabolomics, 2016, 12(7):1-10.